Langley Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.56M Buy
54,838
+47
+0.1% +$1.25K 1.53% 18
2026
Q2
$1.32M Buy
+54,791
New +$1.43M 1.29% 20

Other funds holding PFE

Langley Wealth Management's PFE Position: Q3 2026 in Review

Langley Wealth Management increased its Pfizer (PFE) stake by 0.09% in Q3 2026, buying an estimated $1.25K and bringing the position to 54,838 shares worth $1.56M. The position accounts for 1.53% of the portfolio, ranked #18.

Langley Wealth Management first reported a position in PFE in Q2 2026 and has held it in 2 quarters since. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Langley Wealth Management held 54,838 shares of Pfizer worth $1.56M as of Q3 2026.
  • Langley Wealth Management bought 47 Pfizer shares in Q3 2026, an estimated $1.25K.
  • Pfizer made up 1.53% of Langley Wealth Management's portfolio in Q3 2026, its #18 holding.
  • Langley Wealth Management first reported a position in Pfizer in Q2 2026 and has held it in 2 quarters since.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Langley Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.